inclacumab

Pfizer Terminates Phase III Sickle Cell Study Due to Slow Patient Recruitment
BioSpace
Wed, 03/27/24 - 10:58 am
Pfizer
sickle cell disease
inclacumab
clinical trials
Once lauded for its clinical success, Roche casts off cardio program inclacumab for a mere $2M to Global Blood Therapeutics
Endpoints
Thu, 08/23/18 - 10:11 am
Roche
inclacumab
Global Blood Therapeutics
New anti-inflammatory causes stir at ACC
Pharma Times, UK
Mon, 03/11/13 - 11:00 am
anti-inflammatories
Genmab
Roche
inclacumab
angioplasty